117 related articles for article (PubMed ID: 487645)
1. A longitudinal study of immunological parameters in multiple sclerosis: cell-mediated immunity and complement profiles.
Mar P; Gradl T; Dörner C; Contag I
Clin Exp Immunol; 1979 Jun; 36(3):442-8. PubMed ID: 487645
[TBL] [Abstract][Full Text] [Related]
2. Surface markers on lymphocytes of multiple sclerosis patients.
Nowak J; Wajgt A
Clin Exp Immunol; 1975 Aug; 21(2):278-83. PubMed ID: 1102165
[TBL] [Abstract][Full Text] [Related]
3. Immunological dysfunctions in multiple sclerosis. I. Diminution of 'active' thymus-derived lymphocytes and presence of immunomodulating serum factors.
Kateley JR; Bazzell SJ
Clin Exp Immunol; 1979 Feb; 35(2):218-26. PubMed ID: 312171
[TBL] [Abstract][Full Text] [Related]
4. [Status of local and general immunity in patients with multiple sclerosis].
Totolian NA; Skoromets AA; Barbas IM; Smirnov AIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(2):20-2. PubMed ID: 1647617
[TBL] [Abstract][Full Text] [Related]
5. Multiple sclerosis with reduced and with normal levels of complement in the blood. Clinical and genetic correlation.
Trouillas P; Moindrot J; Betuel H; Quincy C; Aimard G; Devic M
Rev Neurol (Paris); 1976 Oct; 132(10):684-704. PubMed ID: 1006010
[TBL] [Abstract][Full Text] [Related]
6. [T and B lymphocytes in multiple sclerosis].
Argentiero V; Tavolato B; Bertolissi M; Gentile B
Acta Neurol (Napoli); 1977; 32(4):470-2. PubMed ID: 303044
[No Abstract] [Full Text] [Related]
7. [Functional properties of T-lymphocytes in patients with multiple sclerosis].
Zleleznova TA; Ierusalimskiĭ AP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):19-23. PubMed ID: 2529722
[TBL] [Abstract][Full Text] [Related]
8. Humoral and cellular immunity in progressive systemic sclerosis.
Sierakowski S; Bernacka K
Med Interne; 1987; 25(4):233-8. PubMed ID: 3501150
[TBL] [Abstract][Full Text] [Related]
9. Myelin basic protein-responsive blood T lymphocytes in patients with multiple sclerosis.
Hashim GA; Brewen M
J Neurosci Res; 1985; 13(3):349-55. PubMed ID: 2580989
[TBL] [Abstract][Full Text] [Related]
10. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis.
Levitt D; Griffin NB; Egan ML
J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966
[TBL] [Abstract][Full Text] [Related]
11. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
[TBL] [Abstract][Full Text] [Related]
12. [A longitudinal study of immunological parameters in multiple sclerosis (author's transl)].
Simon J; Mar P; Neu I; Kamm S; Schrader A
Nervenarzt; 1980 Mar; 51(3):176-82. PubMed ID: 7453878
[No Abstract] [Full Text] [Related]
13. Disturbances of cell-mediated immunity in ornithosis.
Konopka L; Koba S; Partyka M; Maślanka K; Kryczka W; Szerszén B; Bartosz B
Arch Immunol Ther Exp (Warsz); 1984; 32(2):177-84. PubMed ID: 6385919
[TBL] [Abstract][Full Text] [Related]
14. Peripheral blood B and T-lymphocyte populations in patients with multiple sclerosis. Relationship with clinical activity of the disease and chronic immunosuppressive treatment.
Chalon MP; Sindic CJ; Boon L; Laterre EC
Acta Neurol Belg; 1987; 87(5):245-60. PubMed ID: 3501665
[TBL] [Abstract][Full Text] [Related]
15. T cell subsets in multiple sclerosis. A longitudinal study of exacerbating-remitting cases.
Bach MA; Martin C; Cesaro P; Eizenbaum JF; Degos JD
J Neuroimmunol; 1985; 7(5-6):331-43. PubMed ID: 3871792
[TBL] [Abstract][Full Text] [Related]
16. Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
Laplaud DA; Berthelot L; Miqueu P; Bourcier K; Moynard J; Oudinet Y; Guillet M; Ruiz C; Oden N; Brouard S; Guttmann CR; Weiner HL; Khoury SJ; Soulillou JP
J Neuroimmunol; 2006 Aug; 177(1-2):151-60. PubMed ID: 16806500
[TBL] [Abstract][Full Text] [Related]
17. Immune surveillance in multiple sclerosis patients treated with natalizumab.
Stüve O; Marra CM; Jerome KR; Cook L; Cravens PD; Cepok S; Frohman EM; Phillips JT; Arendt G; Hemmer B; Monson NL; Racke MK
Ann Neurol; 2006 May; 59(5):743-7. PubMed ID: 16634029
[TBL] [Abstract][Full Text] [Related]
18. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
Haahr S; Møller-Larsen A; Pedersen E
Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
[TBL] [Abstract][Full Text] [Related]
19. [Increase in the efficacy of corticosteroid therapy in multiple sclerosis].
Golovkin VI; Chikov Miu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(8):1131-4. PubMed ID: 3876669
[TBL] [Abstract][Full Text] [Related]
20. Identification of three FcR-positive T cell subsets (T gamma, T mu and T gamma mu) in the cerebrospinal fluid of multiple sclerosis patients.
Merrill JE; Biberfeld G; Landin S; Sidén A; Norrby E
Clin Exp Immunol; 1980 Nov; 42(2):345-54. PubMed ID: 6970641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
